As a cancer suppressor miRNA, it completely inhibits breast cancer metastasis and chemotherapy resistance by regulating MT (directly targeting EMT activators, such as ZEB1, CDH2, and vimentin) [24]. The gene discussed is CDH2; the disease is breast carcinoma.